SCHEMBL18859627

SCHEMBL18859627

c1ccc([Si](c2ccccc2)(c2ccccc2)c2ccc(-c3nc4sc5ccccc5c4c4ccccc34)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 1/20 0.36
▸ NUDT1 P36639 2/20 0.35
▸ GPR3 P46089 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ GAA P10253 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ ADK P55263 1/20 0.32
▸ ADORA2A P29274 3/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ ATM Q13315 1/20 0.31
▸ ROCK1 Q13464 1/20 0.30
▸ SCN9A Q15858 1/20 0.30
▸ CASP3 P42574 1/20 0.30
▸ SENP7 Q9BQF6 1/20 0.30
▸ SENP6 Q9GZR1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18803208 0.88 ELANE (0.40) ELANENUDT1GPR3KDM4EGAA
SCHEMBL18859662 0.88 ELANE (0.34) ELANENUDT1GPR3KDM4EGAA
SCHEMBL18859597 0.84 MEN1 (0.47) ELANENUDT1GPR3KDM4EGAA
SCHEMBL22274507 0.82 ELANE (0.37) ELANENUDT1GPR3KDM4EGAA
SCHEMBL18859780 0.82 MAPT (0.38) ELANEGPR3KDM4EGAAMAPT
SCHEMBL18859678 0.80 ELANE (0.36) ELANEGPR3MAPTADKALDH1A1
SCHEMBL18859625 0.79 GPR3 (0.39) ELANENUDT1GPR3KDM4EMAPT
SCHEMBL18859620 0.79 ESR1 (0.39) ELANEKDM4EMAPTNPSR1ADK
SCHEMBL22274340 0.78 MEN1 (0.41) ELANENUDT1KDM4EGAAMAPT
SCHEMBL18859545 0.77 TNKS (0.40) NUDT1GPR3GAAMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10644244-B2 Heterocyclic compound and organic light emitting device using same LT MATERIALS CO., LTD. (KR) 2020-05-05 — — US disclosed
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-18 — — US disclosed
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, CRY2, CYBA ELANE 4401/4885NUDT1 170/4885GPR3 3579/4885
US-10644244-B2 Heterocyclic compound and organic light emitting device using same CRY1, CRY2, CYBA ELANE 4401/4885NUDT1 170/4885GPR3 3579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback